Bioxytran, Inc. (BIXT) financial statements (2022 and earlier)

Company profile

Business Address C/O BIOXYTRAN, INC.
NEEDHAM, MA 02494
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 421703615113
Cash and cash equivalents 421703615113
Receivables  50 2310 
Inventory, net of allowances, customer advances and progress billings    56 
Inventory    56 
Prepaid expense 275     
Total current assets: 3162203643273
Noncurrent Assets
Property, plant and equipment    6822552
Intangible assets, net (including goodwill) 10     
Intangible assets, net (excluding goodwill) 10     
Total noncurrent assets: 10  6822552
TOTAL ASSETS: 326220367265256
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 3487223113791
Accounts payable 170   
Accrued liabilities 844319252726
Taxes payable   0   
Interest and dividends payable   4211816
Other undisclosed accounts payable and accrued liabilities 26322 (34)(8)50
Debt 1,612851227105105105
Due to related parties 30796111016824
Deferred revenue and credits5  
Other undisclosed current liabilities     3231
Total current liabilities: 2,2681,019262131342251
Noncurrent Liabilities
Other undisclosed liabilities    52  
Total liabilities: 2,2681,019262183342251
Stockholders' equity
Stockholders' equity attributable to parent, including: (1,941)(799)(225)542(291)(195)
Preferred stock    0280
Common stock 978685105012
Additional paid in capital 1,7951,3567214,63813,56412,978
Accumulated deficit (4,722)(2,241)(383)(14,201)(13,883)(13,186)
Other undisclosed stockholders' equity attributable to parent 888     
Total stockholders' equity: (1,941)(799)(225)542(291)(195)
TOTAL LIABILITIES AND EQUITY: 326220367265256

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues    191246256
Revenue, net161246256
Cost of revenue
(Cost of Goods and Services Sold)
    (104)(96)(136)
Gross profit:    87150120
Operating expenses (1,269)(1,631) (398)(821)(2,212)
Operating loss: (1,269)(1,631) (311)(671)(2,092)
Nonoperating expense (1,274)(227)(81) (25)(8)
Interest and debt expense (1,015)(42)(8)(8)(18)(8)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 1,01542(206)   
Loss from continuing operations before equity method investments, income taxes: (2,543)(1,858)(296)(318)(714)(2,108)
Other undisclosed income from continuing operations before income taxes     188
Loss from continuing operations before income taxes: (2,543)(1,858)(296)(318)(697)(2,100)
Income tax expense   (0)   
Loss from continuing operations: (2,543)(1,858)(296)(318)(697)(2,100)
Loss from discontinued operations    (318)  
Loss before gain (loss) on sale of properties: (2,543)(1,858)(296)(637)(697)(2,100)
Other undisclosed net income 62     
Net loss: (2,481)(1,858)(296)(637)(697)(2,100)
Net income attributable to noncontrolling interest 62     
Other undisclosed net income (loss) attributable to parent (124)  318  
Net loss available to common stockholders, diluted: (2,543)(1,858)(296)(318)(697)(2,100)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (2,481)(1,858)(296)(637)(697)(2,100)
Comprehensive loss: (2,481)(1,858)(296)(637)(697)(2,100)
Comprehensive income, net of tax, attributable to noncontrolling interest 62     
Comprehensive loss, net of tax, attributable to parent: (2,419)(1,858)(296)(637)(697)(2,100)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: